SARS-CoV-2 Omicron XBB.1.5 variant is highly transmissible and infectious: Study
The XBB.1.5 S protein was also found to be highly resistant to neutralisation antibodies elicited by breakthrough infection with…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
The Lancet
Glenmark Pharma and SaNOtize announce results of its phase-III clinical trials on SaNOtize’s Nitric…
The trial administered to adult COVID-19 patients in India met the key endpoints and demonstrated reductions of viral load of 94…
Omnicron less likely to cause long COVID: UK Study
Researchers at King's College London found the odds of developing long COVID after infection were 20 per cent to 50 per cent lower…
‘The Lancet’ publishes phase-III data of ZyCoV-D
The results of the phase-I part of the phase-I/II clinical trial have already been published in the e-Clinical Medicine Journal of…
COVID vaccine doesn’t raise risk of rare inflammation in children: Lancet
The reporting rate of MIS-C for those without evidence of SARS-CoV-2 infection was 0.3 cases per million vaccinated individuals
Roche’s Faricimab improves and maintains vision in two leading causes of vision loss: Lancet
All four studies met their primary endpoints, showing that people treated with Faricimab up to every four months achieved…
Covaxin shows 50 per cent effectiveness against symptomatic COVID in real-world assessment: Lancet…
The latest study assessed 2,714 hospital workers at the All India Institute of Medical Sciences (AIIMS) in Delhi, from 15th April…
The Lancet publishes Bharat Biotech’s Covaxin phase-III data
The Lancet peer-review confirms the efficacy analysis which demonstrates Covaxin to be effective against COVID-19
Booster shots necessary to beat COVID-19 virus, says Dr Fauci
Pfizer made the proposal in a 52-page presentation to the US FDA, which included data from the recent Israeli study, which showed…
New triple antiviral drugs combo shows promise against COVID-19: Study
Treatment involving a combination of the drugs interferon beta-1b, plus antiviral therapy lopinavir-ritonavir and ribavirin, is…